1.5(top 50%)
impact factor
11.3K(top 2%)
papers
197.2K(top 2%)
citations
106(top 5%)
h-index
1.7(top 50%)
extended IF
13.6K
all documents
208.6K
doc citations
142(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Report on the First International Workshop on interim-PET scan in lymphomaLeukemia and Lymphoma2009641
2Hyperleukocytic Leukemias and Leukostasis: A Review of Pathophysiology, Clinical Presentation and ManagementLeukemia and Lymphoma2000319
3CD19 Antigen in Leukemia and Lymphoma Diagnosis and ImmunotherapyLeukemia and Lymphoma1995288
4Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook FLeukemia and Lymphoma2001270
5Indirubin and Meisoindigo in the Treatment of Chronic Myelogenous Leukemia in ChinaLeukemia and Lymphoma2002261
6Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myelomaLeukemia and Lymphoma2013251
7Granulocytic sarcoma: 32 cases and review of the literatureLeukemia and Lymphoma2006250
818-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CTLeukemia and Lymphoma2000244
9Rituximab-related viral infections in lymphoma patientsLeukemia and Lymphoma2007235
10Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinibLeukemia and Lymphoma2008235
11Epidemiology of myeloproliferative neoplasms in the United StatesLeukemia and Lymphoma2014205
12Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 casesLeukemia and Lymphoma2011204
13Improved Outcome of Zygomycosis in Patients with Hematological Diseases?Leukemia and Lymphoma2004203
14Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panelLeukemia and Lymphoma2011202
15Risk of Febrile Neutropenia among Patients with Intermediate-grade non-Hodgkin's Lymphoma Receiving CHOP ChemotherapyLeukemia and Lymphoma2003199
16Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)Leukemia and Lymphoma2004193
17Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphomaLeukemia and Lymphoma2010192
18Renal failure in multiple myeloma: Incidence, correlations, and prognostic significanceLeukemia and Lymphoma2007190
19Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myelomaLeukemia and Lymphoma2008185
20Results of First Salvage Therapy for Patients Refractory to a Fludarabine Regimen in Chronic Lymphocytic LeukemiaLeukemia and Lymphoma2002181
21Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemiaLeukemia and Lymphoma2008181
22Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate?Leukemia and Lymphoma2017181
23Mastocytosis: Pathology, genetics, and current options for therapyLeukemia and Lymphoma2005180
24Targeting the apoptosis pathway in hematologic malignanciesLeukemia and Lymphoma2014179
25L-Asparaginase and PEG Asparaginase— Past, Present, and FutureLeukemia and Lymphoma1993177
26Primary Non-Hodgkin's Lymphoma of the LiverLeukemia and Lymphoma1998177
27The Cytogenetic Scenario of Chronic Myeloid LeukemiaLeukemia and Lymphoma1993171
28Clinical Features, Treatment and Outcome in a Series of 93 Patients with Low-Grade Gastric MALT LymphomaLeukemia and Lymphoma1997171
29Type I Interferon as a Link Between Innate and Adaptive Immunity through Dendritic Cell StimulationLeukemia and Lymphoma2004165
30Autoimmune Phenomena in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaLeukemia and Lymphoma2002164
31Rituximab in chronic cold agglutinin disease: a prospective study of 20 patientsLeukemia and Lymphoma2006164
32Serum β2-Microglobulin and Serum Thymidine Kinase are Independent Predictors of Progression-Free Survival in Chronic Lymphocytic Leukemia and ImmunocytomaLeukemia and Lymphoma1996163
33Apoptosis Overview Emphasizing the Role of Oxidative Stress, DNA Damage and Signal- Transduction PathwaysLeukemia and Lymphoma1995162
34Recent Results on the Biology of Hodgkin and Reed-Sternberg cells: II. Continuous Cell LinesLeukemia and Lymphoma1993157
35Skin lesions in chronic lymphocytic leukemiaLeukemia and Lymphoma2007154
36Ovarian Injury and Modern Options to Preserve Fertility in Female Cancer Patients Treated with High Dose Radio-Chemotherapy for Hemato-Oncological Neoplasias and other CancersLeukemia and Lymphoma1999153
37Integrin-Mediated Drug Resistance in Multiple MyelomaLeukemia and Lymphoma2000152
38Bone marrow-derived mesenchymal stem cellsLeukemia and Lymphoma2005152
39Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failureLeukemia and Lymphoma2013149
40Fludarabine and Arabinosylcytosine Therapy of Refractory and Relapsed Acute Myelogenous LeukemiaLeukemia and Lymphoma1993147
41Abnormal T-cell Function in B-cell Chronic Lymphocytic LeukaemiaLeukemia and Lymphoma2003147
42Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)Leukemia and Lymphoma2015147
43Regulation of Hematopoiesis by Microvascular EndotheliumLeukemia and Lymphoma1997146
44Cardiac morbidity following modern treatment for Hodgkin lymphoma: Supra-additive cardiotoxicity of doxorubicin and radiation therapyLeukemia and Lymphoma2008145
45Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonatesLeukemia and Lymphoma2008144
46Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single centerLeukemia and Lymphoma2011144
47Detection of molecular targets on the surface of CD34+/CD38− stem cells in various myeloid malignanciesLeukemia and Lymphoma2006142
48Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasiaLeukemia and Lymphoma2008141
49Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemiaLeukemia and Lymphoma2013140
50PECAM-1: Its Expression and Function as a Cell Adhesion Molecule on Hemopoietic and Endothelial CellsLeukemia and Lymphoma1995139